Q4 2024 · 13F-HR
First Light Asset Management, LLCholdings as filed
Filed 2025-02-14 · accession 0001839882-25-009258
$1.05B
Reported value
36
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 69913P105 | FNAUSD | PARAGON 28 INC | $109.3M | 10.5% | 10,580,467 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS LIMITED | $97.2M | 9.30% | 5,805,184 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $74.3M | 7.11% | 4,506,795 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $60.2M | 5.76% | 1,969,221 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORPORATION | $57.0M | 5.45% | 1,226,255 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $53.3M | 5.10% | 1,261,246 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $52.2M | 4.99% | 3,167,585 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS | $45.5M | 4.35% | 1,160,580 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS INC | $45.3M | 4.33% | 885,453 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES | $38.8M | 3.71% | 430,500 | Common | SOLE |
| 42225T107 | HCAT | HEALTH CATALYST INC | $37.1M | 3.55% | 5,241,121 | Common | SOLE |
| 71377E105 | PFMTUSD | PERFORMANT HEALTHCARE, INC. | $34.3M | 3.28% | 11,346,649 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $32.5M | 3.11% | 470,192 | Common | SOLE |
| 602496101 | MDXG | MIMEDX GROUP INC | $32.2M | 3.08% | 3,343,861 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $32.1M | 3.07% | 763,607 | Common | SOLE |
| 759910102 | KRMD | KORU MEDICAL SYSTEMS INC | $22.8M | 2.18% | 5,915,434 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $22.1M | 2.12% | 1,681,110 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $20.8M | 1.99% | 780,639 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $16.8M | 1.61% | 313,782 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $15.9M | 1.53% | 1,136,982 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $15.4M | 1.48% | 383,310 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $14.7M | 1.41% | 93,088 | Common | SOLE |
| 124155102 | BFLY | BUTTERFLY NETWORK INC | $12.5M | 1.19% | 3,994,620 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $11.9M | 1.14% | 82,455 | Common | SOLE |
| 032724106 | ANAB | ANAPTYS BIO INC | $11.5M | 1.10% | 868,882 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $10.8M | 1.03% | 398,855 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $10.5M | 1.01% | 292,117 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $9.9M | 0.95% | 420,431 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $9.6M | 0.92% | 2,328,768 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH | $9.5M | 0.90% | 309,389 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $8.8M | 0.84% | 33,821 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $8.7M | 0.83% | 139,757 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC CLASS A | $7.3M | 0.70% | 546,822 | Common | SOLE |
| 81727U105 | SENS1GBP | SENSEONICS HOLDINGS INC | $3.4M | 0.32% | 6,431,799 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $603,225 | 0.06% | 53,620 | Common | SOLE |
| 464287648 | IWO | ISHARES RUSSELL 2000 GROWTH ETF | $347,687 | 0.03% | 1,208 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.